CONDYLOX (PODOFILOX) GEL 0.5%

U.S

Revision date : 2017-10-02

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

204-881-4/128-37-0

Name of the chemical

2,6-di-tert-butyl-p-cresol

Concentration

Proprietary

EC/CAS

64-17-5

Name of the chemical

Ethanol

Concentration

200-578-

EC/CAS

200-289-5/56-81-5

Name of the chemical

glycerol

Concentration

Proprietary

EC/CAS

9004-64-2

Name of the chemical

hydroxypropylcellulose

Concentration

Proprietary

EC/CAS

200-018-0/50-21-5

Name of the chemical

lactic acid

Concentration

Proprietary

General Information

Revision date

2017-10-02

Product name

CONDYLOX (PODOFILOX) GEL 0.5%

Chemical name

For

1.2.1 Relevant identified uses

of the SUBSTANCE Anticholinergic Gel Human Pharmaceutical

1.2.2. Uses advised against

Non-Pharmaceutical Use

supplier name

U.S

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

Company Information

company name

U.S

e-mail address of the competent person responsible for the Safety Data Sheet

SDS@Allergan.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is a clear, colorless gel with an alcohol odor supplied in tubes

Health hazards

The chief health hazard associated with overexposures during normal use and handling is the potential for irritation of contaminated skin. The active ingredient is toxic if swallowed and in contact with skin. Prolonged or chronic skin contact be harmful and cause systemic effects. In therapeutic use, the most common systemic adverse effect reported is headache. The most common adverse effects at the site of application include inflammation, redness, burning, skin erosion, pain, itching and bleeding. Less common adverse effects reported include peeling, scabbing, discoloration, tenderness, dryness, crusting, fissures, soreness, ulceration, swelling/edema, tingling, rash, and blisters. Therapeutic use of may also cause nausea, vomiting, fever, diarrhea, bone marrow depression, and oral ulcers. If vapors or mists created from the gel are inhaled, irritation of the respiratory system can occur. Podofilox may cause harm to the fetus, based on animal data. Animal studies indicate mutagenic potential by causing chromosomal breaks in mouse in vivo micronucleus tests. Some components are suspect carcinogens. Refer to Section 11 (Toxicological Information) for more information on potential health effects from therapeutic use. Reactivity Hazards: This product is not reactive. Flammability Hazards: The Gel is a Class 1B flammable liquid that is readily ignited under almost all conditions. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon, sodium and nitrogen oxides and acrolein).

Environmental hazards

Large quantities released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations: Emergency responders should wear appropriate protection for situation to which they respond.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.